Literature DB >> 35358301

IL10 Secretion Endows Intestinal Human iNKT Cells with Regulatory Functions Towards Pathogenic T Lymphocytes.

Claudia Burrello1, Francesco Strati1, Georgia Lattanzi1,2, Angelica Diaz-Basabe1,2, Erika Mileti1, Maria Rita Giuffrè1, Gianluca Lopez3, Fulvia Milena Cribiù3, Elena Trombetta4, Marinos Kallikourdis5,6, Marco Cremonesi6, Francesco Conforti7, Fiorenzo Botti7,8, Laura Porretti4, Maria Rescigno5, Maurizio Vecchi7,9, Massimo C Fantini10, Flavio Caprioli7,9, Federica Facciotti1,11.   

Abstract

BACKGROUND AND AIMS: Invariant natural killer T [iNKT] cells perform pleiotropic functions in different tissues by secreting a vast array of pro-inflammatory and cytotoxic molecules. However, the presence and function of human intestinal iNKT cells capable of secreting immunomodulatory molecules such as IL-10 has never been reported so far. Here we describe for the first time the presence of IL10-producing iNKT cells [NKT10 cells] in the intestinal lamina propria of healthy individuals and of Crohn's disease [CD] patients.
METHODS: Frequency and phenotype of NKT10 cells were analysed ex vivo from intestinal specimens of Crohn's disease [n = 17] and controls [n = 7]. Stable CD-derived intestinal NKT10 cell lines were used to perform in vitro suppression assays and co-cultures with patient-derived mucosa-associated microbiota. Experimental colitis models were performed by adoptive cell transfer of splenic naïve CD4+ T cells in the presence or absence of IL10-sufficient or -deficient iNKT cells. In vivo induction of NKT10 cells was performed by administration of short chain fatty acids [SCFA] by oral gavage.
RESULTS: Patient-derived intestinal NKT10 cells demonstrated suppressive capabilities towards pathogenic CD4+ T cells. The presence of increased proportions of mucosal NKT10 cells associated with better clinical outcomes in CD patients. Moreover, an intestinal microbial community enriched in SCFA-producing bacteria sustained the production of IL10 by iNKT cells. Finally, IL10-deficient iNKT cells failed to control the pathogenic activity of adoptively transferred CD4+ T cells in an experimental colitis model.
CONCLUSIONS: These results describe an unprecedentd IL10-mediated immunoregulatory role of intestinal iNKT cells in controlling the pathogenic functions of mucosal T helper subsets and in maintaining the intestinal immune homeostasis.
© The Author(s) 2022. Published by Oxford University Press on behalf of European Crohn’s and Colitis Organisation.

Entities:  

Keywords:  Crohn’s disease; IL10; SCFA; iNKT cells; microbiota

Mesh:

Substances:

Year:  2022        PMID: 35358301      PMCID: PMC9455792          DOI: 10.1093/ecco-jcc/jjac049

Source DB:  PubMed          Journal:  J Crohns Colitis        ISSN: 1873-9946            Impact factor:   10.020


  67 in total

1.  Peroxisome-derived lipids are self antigens that stimulate invariant natural killer T cells in the thymus.

Authors:  Federica Facciotti; Gundimeda S Ramanjaneyulu; Marco Lepore; Sebastiano Sansano; Marco Cavallari; Magdalena Kistowska; Sonja Forss-Petter; Guanghui Ni; Alessia Colone; Amit Singhal; Johannes Berger; Chengfeng Xia; Lucia Mori; Gennaro De Libero
Journal:  Nat Immunol       Date:  2012-03-18       Impact factor: 25.606

2.  Invariant NKT cells producing IL-4 or IL-10, but not IFN-gamma, inhibit the Th1 response in experimental autoimmune encephalomyelitis, whereas none of these cells inhibits the Th17 response.

Authors:  Sae Jin Oh; Doo Hyun Chung
Journal:  J Immunol       Date:  2011-05-13       Impact factor: 5.422

3.  Intestinal IFN-γ-producing type 1 regulatory T cells coexpress CCR5 and programmed cell death protein 1 and downregulate IL-10 in the inflamed guts of patients with inflammatory bowel disease.

Authors:  Johanna Sophie Alfen; Paola Larghi; Federica Facciotti; Nicola Gagliani; Roberto Bosotti; Moira Paroni; Stefano Maglie; Paola Gruarin; Chiara Maria Vasco; Valeria Ranzani; Cristina Frusteri; Andrea Iseppon; Monica Moro; Maria Cristina Crosti; Stefano Gatti; Massimiliano Pagani; Flavio Caprioli; Sergio Abrignani; Richard A Flavell; Jens Geginat
Journal:  J Allergy Clin Immunol       Date:  2018-01-31       Impact factor: 10.793

Review 4.  Inflammatory bowel disease.

Authors:  Arthur Kaser; Sebastian Zeissig; Richard S Blumberg
Journal:  Annu Rev Immunol       Date:  2010       Impact factor: 28.527

5.  Regulatory T cell-derived interleukin-10 limits inflammation at environmental interfaces.

Authors:  Yuri P Rubtsov; Jeffrey P Rasmussen; Emil Y Chi; Jason Fontenot; Luca Castelli; Xin Ye; Piper Treuting; Lisa Siewe; Axel Roers; William R Henderson; Werner Muller; Alexander Y Rudensky
Journal:  Immunity       Date:  2008-04       Impact factor: 31.745

6.  Autocrine regulation of IL-21 production in human T lymphocytes.

Authors:  Flavio Caprioli; Massimiliano Sarra; Roberta Caruso; Carmine Stolfi; Daniele Fina; Giuseppe Sica; Thomas T MacDonald; Francesco Pallone; Giovanni Monteleone
Journal:  J Immunol       Date:  2008-02-01       Impact factor: 5.422

7.  Impaired SLAM-SLAM homotypic interaction between invariant NKT cells and dendritic cells affects differentiation of IL-4/IL-10-secreting NKT2 cells in nonobese diabetic mice.

Authors:  Denis V Baev; Simone Caielli; Francesca Ronchi; Margherita Coccia; Federica Facciotti; Kim E Nichols; Marika Falcone
Journal:  J Immunol       Date:  2008-07-15       Impact factor: 5.422

Review 8.  Tissue-specific functions of invariant natural killer T cells.

Authors:  Catherine M Crosby; Mitchell Kronenberg
Journal:  Nat Rev Immunol       Date:  2018-09       Impact factor: 53.106

9.  MICCA: a complete and accurate software for taxonomic profiling of metagenomic data.

Authors:  Davide Albanese; Paolo Fontana; Carlotta De Filippo; Duccio Cavalieri; Claudio Donati
Journal:  Sci Rep       Date:  2015-05-19       Impact factor: 4.379

10.  Short-term Oral Antibiotics Treatment Promotes Inflammatory Activation of Colonic Invariant Natural Killer T and Conventional CD4+ T Cells.

Authors:  Claudia Burrello; Federica Garavaglia; Fulvia Milena Cribiù; Giulia Ercoli; Silvano Bosari; Flavio Caprioli; Federica Facciotti
Journal:  Front Med (Lausanne)       Date:  2018-02-07
View more
  1 in total

Review 1.  Harnessing invariant natural killer T cells to control pathological inflammation.

Authors:  Nikhila S Bharadwaj; Jenny E Gumperz
Journal:  Front Immunol       Date:  2022-09-15       Impact factor: 8.786

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.